Pneumococcal Vaccines Market Sets Course to Surpass US$ 13.3 Billion by 2033

Pneumococcal vaccines market size, which offer a powerful defence against illnesses caused by the Streptococcus pneumoniae bacteria, are an essential part of world health. These bacteria are harmful because they can lead to a number of illnesses, including sepsis, meningitis, and pneumonia. They pose a particular risk to small children, the elderly, and those with …